Developed in the 1990s, Universal Serial Bus (USB) technology made it easier to connect computers with peripherals or external devices. It has since become the industry standard and is now used in ...
Upstream Bio has sailed to a phase 2 win in sinusitis and plans to push its candidate forward against a competitive current. Investigators randomized 81 adults with chronic rhinosinusitis with nasal ...
– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...
Upstream Bio, Inc. presented data at the European Academy of Allergy & Clinical Immunology Congress highlighting the advantages of verekitug, a treatment targeting the TSLP receptor, over tezepelumab, ...
The last time I spoke about Upstream Bio, Inc. (UPB), it was in a Seeking Alpha article entitled "Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study." With respect to ...
New analyses of efficacy endpoints from the Phase 2 VIBRANT trial of verekitug in CRSwNP to be presented during the late-breaking poster session - ...
Phase 2 trial launched for verekitug in COPD, expanding treatment indications for severe respiratory conditions. Top data expected in 2026. Upstream Bio, Inc. has initiated a global Phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results